Furosemide vs Placebo in Severe Preeclampsia Postpartum
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 186 participants.
Also called NCT07648251
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 186 participants
- Sponsor
- Universidad Nacional Autonoma de Honduras
- Registry
-
NCT07648251
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Honduras
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07648251. Randomized; triple masking; primary purpose treatment. Start 2026-11-02 (anticipated); primary completion 2027-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Furosemide vs Placebo in Severe Preeclampsia Postpartum
- Acronym
- FUROPE
- Condition
- Severe Preeclampsia
- Intervention (Drug)
- Furosemide
- Intervention (Drug)
- Folic Acid 5 MG
- Lead sponsor
- Universidad Nacional Autonoma de Honduras
Record details
- Record id
cardio:ct-nct07648251- Content hash
ea80634c2c3afb2cfe6f1414c62aa6825b5a4e57372d01a0d4632ccf22f6d4a3